Targeting of Alpha-Hemolysin by Active or Passive Immunization Decreases Severity of USA300 Skin Infection in a Mouse Model

• Published in: The Journal of infectious diseases 2010-10, Vol.202 (7), p.1050-1058
• Main Authors: Kennedy, Adam D., Wardenburg, Juliane Bubeck, Gardner, Donald J., Long, Daniel, Whitney, Adeline R., Braughton, Kevin R., Schneewind, Olaf, DeLeo, Frank R.
• Format: Article
• Language: English
• Subjects: Abscesses; Animals; Antibodies; BACTERIA; Bacterial Toxins - antagonists & inhibitors; Biological and medical sciences; Disease models; Disease Models, Animal; Female; Fundamental and applied biological sciences. Psychology; Gene Deletion; Hemolysin Proteins - antagonists & inhibitors; Hemolysin Proteins - deficiency; Humans; Immunization; Immunization - methods; Immunization, Passive - methods; Infections; Infectious diseases; Lesions; Medical sciences; Mice; Mice, Inbred BALB C; Microbiology; Passive immunization; Skin; Skin - pathology; Staphylococcal Skin Infections - immunology; Staphylococcal Skin Infections - microbiology; Staphylococcus aureus; Staphylococcus aureus - immunology; Staphylococcus aureus - pathogenicity; Virulence
• ISSN: 0022-1899; 1537-6613
• DOI: 10.1086/656043

Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) infections are predominantly those affecting skin and soft tissues. Although progress has been made, our knowledge of the molecules that contribute to the pathogenesis of CA-MRSA skin infections is incomplete. We tested the hypothesis that alphahemolysin (Hla) contributes to the severity of USA300 skin infections in mice and determined whether vaccination against Hla reduces disease severity. Isogenic hla-negative (Δhla) strains caused skin lesions in a mouse infection model that were significantly smaller than those caused by wild-type USA300 and Newman strains. Moreover, infection due to wild-type strains produced dermonecrotic skin lesions, whereas there was little or no dermonecrosis in mice infected with Δhla strains. Passive immunization with Hla-specific antisera or active immunization with a nontoxigenic form of Hla significantly reduced the size of skin lesions caused by USA300 and prevented dermonecrosis.We conclude that Hla is a potential target for therapeutics or vaccines designed to moderate severe S. aureus skin infections.